Global Genome Comparative Analysis Reveals Insights of Resistome and Life-Style Adaptation of Pseudomonas putida Strain T2-2 in Oral Cavity
Table 3
Antibiogram of Pseudomonas putida strain T2-2. Antimicrobial compounds with MICs higher than expected were regarded as resistant by strain T2-2 and marked as “R” while the compounds with lower or equal to expected MICs were interpreted as sensitive for strain T2-2 and were marked as “S”.
The following antibiotic(s) are suppressed from analysis: aztreonam
Susceptibility information
Card:
AST-GN83
Lot number: 673305210
Expires:
April 23, 2015 12:00 SGT
Completed:
July 31, 2014, 06:17 SGT
Status: final
Analysis time:
15.50 hours
Antimicrobial
MIC
Interpretation
Antimicrobial
MIC
Interpretation
Ampicillin
>=32
R
Ceftriaxone
8
S
Amoxicillin/clavulanic acid
>=32
R
Cefepime
<=1
S
Ampicillin/sulbactam
>=32
R
Aztreonam
Piperacillin/tazobactam
8
S
Meropenem
4
S
Cefazolin
>=64
R
Amikacin
<=2
S
Cefuroxime
>=64
R
Gentamicin
<=1
S
Cefuroxime axetil
>=64
R
Ciprofloxacin
0.5
S
Cefoxitin
>=64
R
Nitrofurantoin
>=512
R
Cefotaxime
8
S
Trimethoprim/sulfamethoxazole
>=320
R
Ceftazidime
2
S
+ = deduced drug, * = AES modified, and ** = user modified
AES findings:
Last modified: May 28, 2014, 14:17 SGT
Parameter set:
global CLSI-based+natural resistance
Confidence level: analysis not performed
Action
Name (user ID)
Date/time
Comment
Reviewed by:
labsuper
July 31, 2014, 14:07 SGT
Installed VITEK 2 systems version: 07.01. MIC interpretation guideline: global CLSI-based. Therapeutic interpretation guideline: natural resistance. AES parameter set name: global CLSI-based+natural resistance. AES parameter last modified: May 28, 2014, 14:17 SGT.
